{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3CLpro", "Molecular docking", "PLpro", "Phenylethanoid glycosides", "SARS-CoV-2 proteases", "Traditional Chinese Medicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36817956", "DateRevised": {"Year": "2023", "Month": "02", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1016/j.csbj.2023.02.020"], "Journal": {"ISSN": "2001-0370", "JournalIssue": {"Volume": "21", "PubDate": {"Year": "2023"}}, "Title": "Computational and structural biotechnology journal", "ISOAbbreviation": "Comput Struct Biotechnol J"}, "ArticleTitle": "<i>In silico</i> screening of phenylethanoid glycosides, a class of pharmacologically active compounds as natural inhibitors of SARS-CoV-2 proteases.", "Pagination": {"StartPage": "1461", "EndPage": "1472", "MedlinePgn": "1461-1472"}, "Abstract": {"AbstractText": ["Since the advent of Covid-19, several natural products have been investigated regarding their <i>in silico</i> interactions with SARS-CoV-2 proteases - 3CL<sup>pro</sup> and PL<sup>pro</sup>, two of the most important pharmacological targets for antiviral development. Phenylethanoid glycosides (PG) are a class of natural products present in important medicinal plants and a drug containing this group of active ingredients has been successfully used in the treatment of Covid-19 in China. Thus, a dataset with 567 derivatives of this class was built from reviews published between 1994 and 2020, and their interaction against both SARS-CoV-2 proteases was investigated. The virtual screening was performed by filtering the PGs through the evaluation of scores based on the AutoDock Vina, GOLD/ChemPLP, and GOLD/GoldScore evaluation functions. The bRO5 pharmacokinetic parameters of the PGs ranked in the previous step were analyzed and their interaction with key amino acid residues of the 3CL<sup>pro</sup> and PL<sup>pro</sup> enzymes was evaluated. Ninety-eight compounds were identified by computational approaches against PL<sup>pro</sup> and 80 PGs against 3CL<sup>pro</sup>. Of these, four interacted with key catalytic residues of PL<sup>pro</sup>, which is an indicative of inhibitory activity, and three compounds interacted with catalytic key residues of 3CL<sup>pro</sup>. Of these, five PGs occur in plants of the Traditional Chinese Medicine (TCM), while two are components of plants/formulations currently used in the Covid-19 protocols in China. The data presented here show the potential of PGs as selective inhibitors of SARS-CoV-2 3CL<sup>pro</sup> and PL<sup>pro</sup>."], "CopyrightInformation": "\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programa de P\u00f3s-gradua\u00e7\u00e3o Multic\u00eantrico em Ci\u00eancias Fisiol\u00f3gicas, Centro de Ci\u00eancias da Sa\u00fade, Instituto de Biodiversidade e Sustentabilidade NUPEM, Universidade Federal do Rio de Janeiro, Maca\u00e9, RJ 27965045, Brazil."}], "LastName": "Cheohen", "ForeName": "Caio Felipe de Araujo Ribas", "Initials": "CFAR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programa de P\u00f3s-gradua\u00e7\u00e3o em Biologia Computacional e Sistemas, Instituto Oswaldo Cruz, Manguinhos, Rio de Janeiro, RJ 21041361, Brazil."}], "LastName": "Esteves", "ForeName": "Maria Eduarda Alves", "Initials": "MEA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Farm\u00e1cia, Centro de Ci\u00eancias da Sa\u00fade, Bl. A 2\u00ba andar, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}, {"Identifier": [], "Affiliation": "Programa de P\u00f3s-gradua\u00e7\u00e3o em Biotecnologia Vegetal e Bioprocessos, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}], "LastName": "da Fonseca", "ForeName": "Thamirys Silva", "Initials": "TS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programa de P\u00f3s-gradua\u00e7\u00e3o em Biotecnologia Vegetal e Bioprocessos, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}], "LastName": "Leal", "ForeName": "Carla Monteiro", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Farm\u00e1cia, Centro de Ci\u00eancias da Sa\u00fade, Bl. A 2\u00ba andar, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}], "LastName": "Assis", "ForeName": "Fernanda de Lemos Fernandes", "Initials": "FLF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Farm\u00e1cia, Centro de Ci\u00eancias da Sa\u00fade, Bl. A 2\u00ba andar, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}, {"Identifier": [], "Affiliation": "Programa de P\u00f3s-gradua\u00e7\u00e3o em Biotecnologia Vegetal e Bioprocessos, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}], "LastName": "Campos", "ForeName": "Mariana Freire", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Farm\u00e1cia, Centro de Ci\u00eancias da Sa\u00fade, Bl. A 2\u00ba andar, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}], "LastName": "Rebelo", "ForeName": "Raianne Soares", "Initials": "RS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Farm\u00e1cia, Centro de Ci\u00eancias da Sa\u00fade, Bl. A 2\u00ba andar, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}], "LastName": "Allonso", "ForeName": "Diego", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Pesquisas de Produtos Naturais, Centro de Ci\u00eancias da Sa\u00fade, Bl. H, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}], "LastName": "Leit\u00e3o", "ForeName": "Gilda Guimar\u00e3es", "Initials": "GG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programa de P\u00f3s-gradua\u00e7\u00e3o Multic\u00eantrico em Ci\u00eancias Fisiol\u00f3gicas, Centro de Ci\u00eancias da Sa\u00fade, Instituto de Biodiversidade e Sustentabilidade NUPEM, Universidade Federal do Rio de Janeiro, Maca\u00e9, RJ 27965045, Brazil."}, {"Identifier": [], "Affiliation": "Programa de P\u00f3s-gradua\u00e7\u00e3o em Biologia Computacional e Sistemas, Instituto Oswaldo Cruz, Manguinhos, Rio de Janeiro, RJ 21041361, Brazil."}], "LastName": "da Silva", "ForeName": "Manuela Leal", "Initials": "ML"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Farm\u00e1cia, Centro de Ci\u00eancias da Sa\u00fade, Bl. A 2\u00ba andar, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}, {"Identifier": [], "Affiliation": "Programa de P\u00f3s-gradua\u00e7\u00e3o em Biotecnologia Vegetal e Bioprocessos, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941902, Brazil."}], "LastName": "Leit\u00e3o", "ForeName": "Suzana Guimar\u00e3es", "Initials": "SG"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Comput Struct Biotechnol J", "NlmUniqueID": "101585369", "ISSNLinking": "2001-0370"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727\u2013733.", "ArticleIdList": ["PMC7092803", "31978945"]}, {"Citation": "Creech C.B., Walker S.C., Samuels R.J. SARS-CoV-2. Vaccines. 2021;325:1318\u20131320.", "ArticleIdList": ["33635317"]}, {"Citation": "Lopes-Pacheco M., Silva P.L., Cruz F.F., Battaglini D., Robba C., Pelosi P., Morales M.M., Caruso Neves C., Rocco P.R.M. Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies. Front Physiol. 2021;12:1\u201323.", "ArticleIdList": ["PMC7876335", "33584343"]}, {"Citation": "Robinson P.C., Liew D.F.L., Tanner H.L., Grainger J.R., Dwek R.A. COVID-19 therapeutics : Chall Dir Future. 2022;119:1\u201310.", "ArticleIdList": ["PMC9169797", "35385354"]}, {"Citation": "Saberiyan M., Karimi E., Khademi Z., Movahhed P., Safi A., Mehri-Ghahfarrokhi A. SARS-CoV-2: phenotype, genotype, and characterization of different variants. Cell Mol Biol Lett. 2022;27:50.", "ArticleIdList": ["PMC9204680", "35715738"]}, {"Citation": "Vinjamuri S., Li L., Bouvier M. SARS-CoV-2 ORF8: one protein, seemingly one structure, and many functions. Front Immunol. 2022 doi: 10.3389/fimmu.2022.1035559.", "ArticleIdList": ["10.3389/fimmu.2022.1035559", "PMC9637571", "36353628"]}, {"Citation": "Yadav R., Chaudhary J.K., Jain N., Chaudhary P.K., Khanra S., Dhamija P., Sharma A., Kumar A., Handu S. Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells. 2021;10:821.", "ArticleIdList": ["PMC8067447", "33917481"]}, {"Citation": "Arya R., Kumari S., Pandey B., Mistry H., Bihani S.C., Das A., Prashar V., Gupta G.D., Panicker L., Kumar M. Structural insights into SARS-CoV-2 proteins. J Mol Biol. 2021;433", "ArticleIdList": ["PMC7685130", "33245961"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science. 2020;368:409\u2013412.", "ArticleIdList": ["PMC7164518", "32198291"]}, {"Citation": "Yadav R., Chaudhary J.K., Jain N., Chaudhary P.K., Khanra S., Dhamija P., Sharma A., Kumar A., Handu S. Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells. 2021;10:821.", "ArticleIdList": ["PMC8067447", "33917481"]}, {"Citation": "Bai C., Zhong Q., Gao G.F. Overview of SARS-CoV-2 genome-encoded proteins. Sci China Life Sci. 2022;65:280\u2013294.", "ArticleIdList": ["PMC8362648", "34387838"]}, {"Citation": "Harcourt B.H., Jukneliene D., Kanjanahaluethai A., Bechill J., Severson K.M., Smith C.M., Rota P.A., Baker S.C. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol. 2004;78:13600\u201313612.", "ArticleIdList": ["PMC533933", "15564471"]}, {"Citation": "Osipiuk J., Azizi S.A., Dvorkin S., Endres M., Jedrzejczak R., Jones K.A., Kang S., Kathayat R.S., Kim Y., Lisnyak V.G., Maki S.L., Nicolaescu V., Taylor C.A., Tesar C., Zhang Y.A., Zhou Z., Randall G., Michalska K., Snyder S.A., Dickinson B.C., Joachimiak A. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat Commun. 2021;12:1\u20139.", "ArticleIdList": ["PMC7854729", "33531496"]}, {"Citation": "Jo S., Kim S., Kim D.Y., Kim M.S., Shin D.H. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J Enzym Inhib Med Chem. 2020;35:1539\u20131544.", "ArticleIdList": ["PMC7470085", "32746637"]}, {"Citation": "Khan M.I., Baig M.H., Mondal T., Alorabi M., Sharma T., Dong J.J., Cho J.Y. Impact of the double mutants on spike protein of SARS-CoV-2 B.1.617 lineage to the human ACE2 receptor binding: a structural insight. Viruses. 2021 doi: 10.3390/v13112295.", "ArticleIdList": ["10.3390/v13112295", "PMC8625741", "34835101"]}, {"Citation": "Adem \u015e., Eyupoglu V., Sarfraz I., Rasul A., Zahoor A.F., Ali M., Abdalla M., Ibrahim I.M., Elfiky A.A. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19. Phytomedicine. 2021 doi: 10.1016/j.phymed.2020.153310.", "ArticleIdList": ["10.1016/j.phymed.2020.153310", "PMC7442560", "32948420"]}, {"Citation": "Abdallah H.M., El-Halawany A.M., Sirwi A., El-Araby A.M., Mohamed G.A., Ibrahim S.R.M., Koshak A.E., Asfour H.Z., Awan Z.A., Elfaky M.A. Repurposing of some natural product isolates as sars-cov-2 main protease inhibitors via in vitro cell free and cell-based antiviral assessments and molecular modeling approaches. Pharmaceuticals. 2021;14:1\u201318.", "ArticleIdList": ["PMC8001104", "33806331"]}, {"Citation": "Sharma S., Dash P.K., Sharma S.K., Srivastava A., Kumar J.S., Karothia B.S., Chelvam K.T., Singh S., Gupta A., Yadav R.G., Yadav R., Greeshma T.S., Kushwaha P.K., Kumar R.B., Nagar D.P., Nandan M., Kumar S., Thavaselvam D., Dubey D.K. Emergence and expansion of highly infectious spike protein D614G mutant SARS-CoV-2 in central India. Sci Rep. 2021 doi: 10.1038/s41598-021-95822-w.", "ArticleIdList": ["10.1038/s41598-021-95822-w", "PMC8437943", "34518554"]}, {"Citation": "Khan M.T., Ali A., Wang Q., Irfan M., Khan A., Zeb M.T., Zhang Y.J., Chinnasamy S., Wei D.Q. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2\u2014a molecular dynamic study. J Biomol Struct Dyn. 2020;39:1\u201311.", "ArticleIdList": ["PMC7284144", "32410504"]}, {"Citation": "Jo S., Kim S., Kim D.Y., Kim M.S., Shin D.H. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J Enzym Inhib Med Chem. 2020;35:1539\u20131544.", "ArticleIdList": ["PMC7470085", "32746637"]}, {"Citation": "Leal C.M., Leit\u00e3o S.G., Sausset R., Mendon\u00e7a S.C., Nascimento P.H.A., Caio C.F., Esteves M.E.A., Leal da Silva M., Gondim T.S., Monteiro M.E.S., Tucci A.R., Fintelman-Rodrigues N., Siqueira M.M., Miranda M.D., Costa F.N., Simas R.C., Leit\u00e3o G.G. Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication. Rev Bras De Farmacogn. 2021;5 doi: 10.1007/s43450-021-00162-.", "ArticleIdList": ["10.1007/s43450-021-00162-", "PMC8294293", "34305198"]}, {"Citation": "Tian X.Y., Li M.X., Lin T., Qiu Y., Zhu Y.T., Li X.L., Tao W., di, Wang P., Ren X.X., Chen L.P. A review on the structure and pharmacological activity of phenylethanoid glycosides. Eur J Med Chem. 2021;209", "ArticleIdList": ["33038797"]}, {"Citation": "Shawky E., Nada A.A., Ibrahim R.S. Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses. RSC Adv. 2020;10:27961\u201327983.", "ArticleIdList": ["PMC9055652", "35519104"]}, {"Citation": "Kallingal A., Kundil Thachan, Ayyolath V., Karlapudi A., Muringayil Joseph A.P., T, J. V E. Molecular modeling study of tectoquinone and acteoside from Tectona grandis linn: a new SARS-CoV-2 main protease inhibitor against COVID-19. J Biomol Struct Dyn. 2022;40:1764\u20131775.", "ArticleIdList": ["33036548"]}, {"Citation": "Khattab A.R., Teleb M., Kamel M.S. In silico study of potential anti-SARS cell entry phytoligands from Phlomis aurea: a promising avenue for prophylaxis. Future Virol. 2021;16:761\u2013775.", "ArticleIdList": ["PMC8559586", "34745316"]}, {"Citation": "Wang C.Z., Jia Z.J., Shen X.M. Phenylpropanoid, neolignan and iridoid glycosides from Pedicularis semitorta. Indian J Chem - Sect B Org Med Chem. 1997;36:150\u2013153."}, {"Citation": "Singla R.K., He X., Chopra H., Tsagkaris C., Shen L., Kamal M.A., Shen B. Natural products for the prevention and control of the COVID-19 pandemic: sustainable bioresources. Front Pharm. 2021;12:1\u201337.", "ArticleIdList": ["PMC8671886", "34925017"]}, {"Citation": "Lu Y.-C., Tseng L.-W., Huang Y.-C., Yang C.-W., Chen Y.-C., Chen H.-Y. The potential complementary role of using chinese herbal medicine with western medicine in treating COVID-19 patients: pharmacology network analysis. Pharmaceuticals. 2022;15:794.", "ArticleIdList": ["PMC9323801", "35890093"]}, {"Citation": "Hu K., jie Guan W., Bi Y., Zhang W., Li L., Zhang B., Liu Q., Song Y., Li X., Duan Z., Zheng Q., Yang Z., Liang J., Han M., Ruan L., Wu C., Zhang Y., hua Jia Z., shan Zhong N. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine. 2021 doi: 10.1016/j.phymed.2020.153242.", "ArticleIdList": ["10.1016/j.phymed.2020.153242", "PMC7229744", "33867046"]}, {"Citation": "Runfeng L., Yunlong H., Jicheng H., Weiqi P., Qinhai M., Yongxia S., Chufang L., Jin Z., Zhenhua J., Haiming J., Kui Z., Shuxiang H., Jun D., Xiaobo L., Xiaotao H., Lin W., Nanshan Z., Zifeng Y. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Pharm Res. 2020;156", "ArticleIdList": ["PMC7102548", "32205232"]}, {"Citation": "Jim\u00e9nez C., Riguera R. Phenylethanoid glycosides in plants: structure and biological activity. Nat Prod Rep. 1994;11:591\u2013606.", "ArticleIdList": ["15209134"]}, {"Citation": "Fu G., Pang H., Wong Y. Naturally occurring phenylethanoid glycosides: potential leads for new therapeutics. Curr Med Chem. 2008;15:2592\u20132613.", "ArticleIdList": ["18855681"]}, {"Citation": "Xue Z., Yang B. Phenylethanoid glycosides: research advances in their phytochemistry, pharmacological activity and pharmacokinetics. Molecules. 2016;21:1\u201325.", "ArticleIdList": ["PMC6273160", "27483229"]}, {"Citation": "Wu L., Georgiev M.I., Cao H., Nahar L., El-Seedi H.R., Sarker S.D., Xiao J., Lu B. Therapeutic potential of phenylethanoid glycosides: a systematic review. Med Res Rev. 2020;40:2605\u20132649.", "ArticleIdList": ["32779240"]}, {"Citation": "Dolinsky T.J., Czodrowski P., Li H., Nielsen J.E., Jensen J.H., Klebe G., Baker N.A. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 2007 doi: 10.1093/nar/gkm276.", "ArticleIdList": ["10.1093/nar/gkm276", "PMC1933214", "17488841"]}, {"Citation": "Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u20131612.", "ArticleIdList": ["15264254"]}, {"Citation": "Forli S., Huey R., Pique M.E., Sanner M.F., Goodsell D.S., Olson A.J. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016;11:905\u2013919.", "ArticleIdList": ["PMC4868550", "27077332"]}, {"Citation": "O\u2019Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R. Open Babel: an open chemical toolbox. J Chemin- 2011;3:33.", "ArticleIdList": ["PMC3198950", "21982300"]}, {"Citation": "Hajbabaie R., Harper M.T., Rahman T. Establishing an analogue based in silico pipeline in the pursuit of novel inhibitory scaffolds against the sars coronavirus 2 papain-like protease. Molecules. 2021 doi: 10.3390/molecules26041134.", "ArticleIdList": ["10.3390/molecules26041134", "PMC7924369", "33672721"]}, {"Citation": "Ma C., Sacco M.D., Xia Z., Lambrinidis G., Townsend J.A., Hu Y., Meng X., Szeto T., Ba M., Zhang X., Gongora M., Zhang F., Marty M.T., Xiang Y., Kolocouris A., Chen Y., Wang J. Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and a flipgfp-based reporter assay. ACS Cent Sci. 2021;7:1245\u20131260.", "ArticleIdList": ["PMC8265724", "34341772"]}, {"Citation": "Fu Z., Huang B., Tang J., Liu S., Liu M., Ye Y., Liu Z., Xiong Y., Zhu W., Cao D., Li J., Niu X., Zhou H., Zhao Y.J., Zhang G., Huang H. The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery. Nat Commun. 2021;12:488.", "ArticleIdList": ["PMC7817691", "33473130"]}, {"Citation": "Ullrich S., Nitsche C. The SARS-CoV-2 main protease as drug target. Bioorg Med Chem Lett. 2020;30", "ArticleIdList": ["PMC7331567", "32738988"]}, {"Citation": "Khan R.J., Jha R.K., Amera G.M., Jain M., Singh E., Pathak A., Singh R.P., Muthukumaran J., Singh A.K. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2\u2032-O-ribose methyltransferase. J Biomol Struct Dyn. 2020;0:1\u201314.", "ArticleIdList": ["PMC7189412", "32266873"]}, {"Citation": "B\u00e1ez-Santos Y.M., st. John S.E., Mesecar A.D. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Antivir Res. 2015;115:21\u201338.", "ArticleIdList": ["PMC5896749", "25554382"]}, {"Citation": "Osipiuk J., Azizi S.-A., Dvorkin S., Endres M., Jedrzejczak R., Jones K.A., Kang S., Kathayat R.S., Kim Y., Lisnyak V.G., Maki S.L., Nicolaescu V., Taylor C.A., Tesar C., Zhang Y.-A., Zhou Z., Randall G., Michalska K., Snyder S.A., Dickinson B.C., Joachimiak A. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat Commun. 2021;12:743.", "ArticleIdList": ["PMC7854729", "33531496"]}, {"Citation": "Fu Z., Huang B., Tang J., Liu S., Liu M., Ye Y., Liu Z., Xiong Y., Zhu W., Cao D., Li J., Niu X., Zhou H., Zhao Y.J., Zhang G., Huang H. The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery. Nat Commun. 2021;12:488.", "ArticleIdList": ["PMC7817691", "33473130"]}, {"Citation": "Wang H., Sun Y., Ye W.C., Xiong F., Wu J.J., Yang C.H., Zhao S.X. Antioxidative phenylethanoid and phenolic glycosides from Picrorhiza scrophulariiflora. Chem Pharm Bull (Tokyo) 2004;52:615\u2013617.", "ArticleIdList": ["15133218"]}, {"Citation": "Huang, S., Liao, X., Nie, Q., Ding, L., and Peng, S. (2004) Phenyl and Phenylethyl Glycosides from Picrorhiza scrophulariiflora Introduction.\u00b1Picrorhiza scrophulariiflora Pennell and Picrorhiza kurrooa China, Nepal, and India for the treatment of various immune-system-related diseases. 87, 598\u2013604."}, {"Citation": "Ekins S., Williams A.J., Krasowski M.D., Freundlich J.S. In silico repositioning of approved drugs for rare and neglected diseases. Drug Disco Today. 2011;16:298\u2013310.", "ArticleIdList": ["21376136"]}, {"Citation": "Yang C., Chen E.A., Zhang Y. Protein\u2013ligand docking in the machine-learning era. Molecules. 2022;27:4568.", "ArticleIdList": ["PMC9323102", "35889440"]}, {"Citation": "Macalino S.J.Y., Gosu V., Hong S., Choi S. Role of computer-aided drug design in modern drug discovery. Arch Pharm Res. 2015;38:1686\u20131701.", "ArticleIdList": ["26208641"]}, {"Citation": "Cer\u00f3n-Carrasco J.P. When virtual screening yields to inactive drugs dealing with false theoretical\u2010friends. ChemMedChem. 2022;202200278:1\u20138.", "ArticleIdList": ["PMC9542010", "35726731"]}, {"Citation": "Rao T., Tan Z., Peng J., Guo Y., Chen Y., Zhou H., Ouyang D. The pharmacogenetics of natural products: a pharmacokinetic and pharmacodynamic perspective. Pharm Res. 2019 doi: 10.1016/j.phrs.2019.104283.", "ArticleIdList": ["10.1016/j.phrs.2019.104283", "31129178"]}, {"Citation": "Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J.R., and Hilgenfeld, R. (1999) Coronavirus Main Proteinase (3CL pro) Structure: Basis for Design of Anti-SARS Drugs.", "ArticleIdList": ["12746549"]}, {"Citation": "el Ahdab D., Lagard\u00e8re L., Inizan T.J., C\u00e9lerse F., Liu C., Adjoua O., Jolly L.H., Gresh N., Hobaika Z., Ren P., Maroun R.G., Piquemal J.P. Interfacial water many-body effects drive structural dynamics and allosteric interactions in SARS-CoV-2 main protease dimerization interface. J Phys Chem Lett. 2021;12:6218\u20136226.", "ArticleIdList": ["PMC8262171", "34196568"]}, {"Citation": "Razali R., Asis H., Budiman C. Structure-function characteristics of sars-cov-2 proteases and their potential inhibitors from microbial sources. Microorganisms. 2021 doi: 10.3390/microorganisms9122481.", "ArticleIdList": ["10.3390/microorganisms9122481", "PMC8706127", "34946083"]}, {"Citation": "Fu Z., Huang B., Tang J., Liu S., Liu M., Ye Y., Liu Z., Xiong Y., Zhu W., Cao D., Li J., Niu X., Zhou H., Zhao Y.J., Zhang G., Huang H. The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery. Nat Commun. 2021 10.1038/s41467-020-20718-8.", "ArticleIdList": ["PMC7817691", "33473130"]}, {"Citation": "Luo L., Jiang J., Wang C., Fitzgerald M., Hu W., Zhou Y., Zhang H., Chen S. Analysis on herbal medicines utilized for treatment of COVID-19. Acta Pharm Sin B. 2020;10:1192\u20131204.", "ArticleIdList": ["PMC7251357", "32834949"]}, {"Citation": "Xiong X., Wang P., Su K., Cho W.C., Xing Y. Chinese herbal medicine for coronavirus disease 2019: a systematic review and meta-analysis. Pharm Res. 2020;160", "ArticleIdList": ["PMC7331568", "32622723"]}, {"Citation": "Nile S.H., Kai G. Recent clinical trials on natural products and traditional Chinese medicine combating the COVID-19. Indian J Microbiol. 2021;61:10\u201315.", "ArticleIdList": ["PMC7772620", "33390627"]}, {"Citation": "Li L., Wu Y., Wang J., Yan H., Lu J., Wang Y., Zhang B., Zhang J., Yang J., Wang X., Zhang M., Li Y., Miao L., Zhang H. Potential treatment of COVID-19 with traditional chinese medicine: what herbs can help win the battle with SARS-CoV-2. Engineering. 2021 doi: 10.1016/j.eng.2021.08.020.", "ArticleIdList": ["10.1016/j.eng.2021.08.020", "PMC8552808", "34729244"]}, {"Citation": "Yin L., Gao Y., Li Z., Wang M., Chen K. Analysis of Chinese herbal formulae recommended for COVID-19 in different schemes in China: a data mining approach. Comb Chem High Throughput Screen. 2021;24:957\u2013967.", "ArticleIdList": ["33001008"]}, {"Citation": "SHEN, S.H., ZHANG, C.H., BI, D.H., WEI, F.H., and SUN, Y.H. (2020) METHOD FOR SEPARATING EIGHTEEN COMPONENTS IN TRADITIONAL CHINESE MEDICINE COMPOSITION."}, {"Citation": "Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141\u2013154.", "ArticleIdList": ["PMC7537588", "33024307"]}, {"Citation": "Ohta T., Nakamura S., Nakashima S., Oda Y., Matsumoto T., Fukaya M., Yano M., Yoshikawa M., Matsuda H. Chemical structures of constituents from the whole plant of Bacopa monniera. J Nat Med. 2016;70:404\u2013411.", "ArticleIdList": ["27010932"]}, {"Citation": "Rana A., Bhangalia S., Singh H.P. A new phenylethanoid glucoside from Jacaranda mimosifolia. Nat Prod Res. 2013;27:1167\u20131173.", "ArticleIdList": ["22928593"]}, {"Citation": "Li H.X., Xiao C.J., Wang M., Cui S.J., Li H.F., Wang K.L., Dong X., Jiang B. Four new phenylethanoid glycosides from Ternstroemia gymnanthera and their analgesic activities. Phytochem Lett. 2019;34:25\u201329."}, {"Citation": "Frezza C., Venditti A., Toniolo C., de Vita D., Serafini I., Cicc\u00f2la A., Franceschin M., Ventrone A., Tomassini L., Foddai S., Guiso M., Nicoletti M., Bianco A., Serafini M. Pedicularis L. Genus: systematics, botany, phytochemistry, chemotaxonomy, ethnopharmacology, and other. Plants. 2019 doi: 10.3390/plants8090306.", "ArticleIdList": ["10.3390/plants8090306", "PMC6784095", "31461963"]}, {"Citation": "Ahmad V.U., Arshad S., Bader S., Ahmed A., Iqbal S., Tareen R.B. New phenethyl alcohol glycosides from Stachys parviflora. J Asian Nat Prod Res. 2006;8:105\u2013111.", "ArticleIdList": ["16753790"]}, {"Citation": "Shao S.-Y., Feng Z.-M., Yang Y.-N., Jiang J.-S., Zhang P.-C. Eight new phenylethanoid glycoside derivatives possessing potential hepatoprotective activities from the fruits of Forsythia suspensa. Fitoterapia. 2017;122:132\u2013137.", "ArticleIdList": ["28911849"]}, {"Citation": "Rao T., Tan Z., Peng J., Guo Y., Chen Y., Zhou H., Ouyang D. The pharmacogenetics of natural products: a pharmacokinetic and pharmacodynamic perspective. Pharm Res. 2019;146", "ArticleIdList": ["31129178"]}, {"Citation": "Lipinski C.A. Lead- and drug-like compounds: the rule-of-five revolution. Drug Disco Today Technol. 2004;1:337\u2013341.", "ArticleIdList": ["24981612"]}, {"Citation": "Doak B.C., Over B., Giordanetto F., Kihlberg J. Oral druggable space beyond the rule of 5: Insights from drugs and clinical candidates. Chem Biol. 2014;21:1115\u20131142.", "ArticleIdList": ["25237858"]}, {"Citation": "Doak B.C., Zheng J. How beyond rule of 5 drugs and clinical candidates bind to their targets. J Med Chem. 2015 doi: 10.1021/acs.jmedchem.5b01286.", "ArticleIdList": ["10.1021/acs.jmedchem.5b01286", "26457449"]}, {"Citation": "Doak B.C., Kihlberg J. Drug discovery beyond the rule of 5 - opportunities and challenges. Expert Opin Drug Disco. 2017;12:115\u2013119.", "ArticleIdList": ["27883294"]}, {"Citation": "Pires D.E.V., Blundell T.L., Ascher D.B. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58:4066\u20134072.", "ArticleIdList": ["PMC4434528", "25860834"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:1\u201313.", "ArticleIdList": ["PMC5335600", "28256516"]}, {"Citation": "Sander T., Freyss J., von Korff M., Rufener C. DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model. 2015;55:460\u2013473.", "ArticleIdList": ["25558886"]}, {"Citation": "von Korff M., Sander T. Toxicity-indicating structural patterns. J Chem Inf Model. 2006;46:536\u2013544.", "ArticleIdList": ["16562981"]}, {"Citation": "Ames B.N., Lee F.D., Durston W.E. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci. 1973;70:782\u2013786.", "ArticleIdList": ["PMC433358", "4577135"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.", "ArticleIdList": ["PMC5335600", "28256516"]}, {"Citation": "Dahlgren D., Sj\u00f6blom M., Lennern\u00e4s H. Intestinal absorption-modifying excipients: a current update on preclinical in vivo evaluations. Eur J Pharm Biopharm. 2019;142:411\u2013420.", "ArticleIdList": ["31306749"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors. Science. 2020;368:409\u2013412.", "ArticleIdList": ["PMC7164518", "32198291"]}, {"Citation": "Dai W., Zhang B., Jiang X.M., Su H., Li J., Zhao Y., Xie X., Jin Z., Peng J., Liu F., Li C., Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X., Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science. 2020;368:1331\u20131335.", "ArticleIdList": ["PMC7179937", "32321856"]}, {"Citation": "Kumar Y., Singh H., Patel C.N. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. J Infect Public Health. 2020;13:1210\u20131223.", "ArticleIdList": ["PMC7297718", "32561274"]}, {"Citation": "Nawrot-Hadzik I., Zmudzinski M., Matkowski A., Preissner R., K\u0119sik-Brodacka M., Hadzik J., Drag M., Abel R. Reynoutria rhizomes as a natural source of sars-cov-2 mpro inhibitors\u2013molecular docking and in vitro study. Pharmaceuticals. 2021 10.3390/ph14080742.", "ArticleIdList": ["PMC8399519", "34451839"]}, {"Citation": "Govindaraj R.G., Naderi M., Singha M., Lemoine J., Brylinski M. Large-scale computational drug repositioning to find treatments for rare diseases. NPJ Syst Biol Appl. 2018 doi: 10.1038/s41540-018-0050-7.", "ArticleIdList": ["10.1038/s41540-018-0050-7", "PMC5847522", "29560273"]}, {"Citation": "Mugnai, M.L., Templeton, C., Elber, R., and Thirumalai, D. Role of Long-range Allosteric Communication in Determining the Stability and Disassembly of SARS-COV-2 in Complex with ACE2. 10.1101/2020.11.30.405340."}, {"Citation": "Ibrahim T.M., Ismail M.I., Bauer M.R., Bekhit A.A., Boeckler F.M. Supporting SARS-CoV-2 papain-like protease drug discovery: in silico methods and benchmarking. Front Chem. 2020 doi: 10.3389/fchem.2020.592289.", "ArticleIdList": ["10.3389/fchem.2020.592289", "PMC7674952", "33251185"]}, {"Citation": "Ismail, M.I., Ragab, H.M., Bekhit, A.A., and Ibrahim, T.M. (202AD) Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19. The COVID-19 Resource Centre Is Hosted on Elsevier Connect, the Company \u2019 s Public News and Information."}, {"Citation": "Rao P., Patel R., Shukla A., Parmar P., Rawal R.M., Saraf M., Goswami D. Identifying structural\u2013functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation. Mol Divers. 2022;26:309\u2013329.", "ArticleIdList": ["PMC8023777", "33825097"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "23"}, {"Year": "2023", "Month": "2", "Day": "9"}, {"Year": "2023", "Month": "2", "Day": "9"}, {"Year": "2023", "Month": "2", "Day": "23", "Hour": "9", "Minute": "44"}, {"Year": "2023", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "2", "Day": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36817956", "PMC9920770", "10.1016/j.csbj.2023.02.020", "S2001-0370(23)00065-X"]}}], "PubmedBookArticle": []}